Life Science Webinars

  1. Shifting Strategy: Advanced Approaches To Plasmid Production 9/13/2023

    Explore the benefits of working with a CDMO that has extensive plasmid experience and integrated project teams across the production process.

  2. From Myth To Mastery: Unveiling The Secrets Of Virus Bank Manufacturing 9/12/2023

    It is crucial to start off your product development right. In this webinar, you will learn how to best approach virus bank production. Review best practices, how to overcome common obstacles, and more.

  3. A Robust And Scalable Suspension Platform For AAV Manufacturing 9/12/2023

    Review the demands for AAV manufacturing using a suspension process and the DOE-based strategy used to achieve a scalable process both in terms production and quality of AAV purified.

  4. Kick It Off Right: A Successful Cell Bank Manufacture 9/12/2023

    Learn about best practices for cell bank manufacturing, how to get the most out of your cell bank, the future of closed processing in line with Annex 1, and more.

  5. Industry-Leading Lentiviral Titers Through Optimized Production Technology 8/28/2023

    Learn how innovation scientists from MilliporeSigma optimized the company's VirusExpress® technology to provide industry-leading lentiviral titer and a streamlined approach to accelerate development timelines and de-risk manufacturing.

  6. Cell Therapy Milestones, Challenges, And Forming The Future Of TILs 8/15/2023

    What milestones enabled the evolution of TIL therapies? What does the future hold for TIL therapies? And where should you focus support for an accelerated path forward? Watch to explore these topics and more.

  7. Capabilities And Opportunities Of Innovative Cell Processing System In CGT 8/15/2023

    Discover a system that can automate several steps of your cell therapy workflow while achieving high efficiency, how to optimize cell recovery during harvesting, and more.

  8. Direct CNS Delivery Of Oligonucleotides: Beware Of The Unexpected 8/14/2023

    As we gain more experience in the CNS ASO administration field, we are beginning to see unexpected scenarios arising despite using “well-understood” oligonucleotide backbones.

  9. Best Practices Under ICH E14/S7B For Non-Clinical, Clinical Strategies 8/14/2023

    Scientific experts discuss how the ICH E14/S7B (Q&As) in vitro hERG and in vivo QT assays will be conducted, interpreted, and reported.

  10. Digital Pathology And Machine Learning 8/14/2023

    Learn how digital pathology can advance non-clinical pathology workflows and expand opportunities to improve study outcomes with increased speed and flexibility, data quality, and communication pathways.